Business Wire | Dec 22, 2020 08:30AM EST

Elanco to Participate in the 39th Annual J.P. Morgan Healthcare Conference

Dec. 22, 2020

GREENFIELD, Ind.--(BUSINESS WIRE)--Dec. 22, 2020--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts. He is scheduled to present at 7:30 a.m. ET.

A live audio webcast will be available in the "Events and Presentations" section of Elanco's investor website. A replay will be available for approximately 90 days.

ABOUT ELANCO

Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we're driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose(tm) CSR framework - all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201222005013/en/

CONTACT: Investor Contact: Tiffany Kanaga (302) 897-0668 kanaga_tiffany@elanco.com Media Contact: Colleen Parr Dekker (317) 989-7011 colleen_parr_dekker@elanco.com